Home » Topics » BioWorld Science

BioWorld Science
RSS

New C5a antagonist discovered by Rhone-Poulenc Rorer

June 4, 1997

Banyu developing new anticancer agent

June 4, 1997

Update on HIV research at Sheffield

June 4, 1997

Shire & Janssen acquire rights to Nivalin

June 4, 1997

State University of New York grants license to Noven for anticavity compounds

June 4, 1997

Shaman issued U.S. patents for type II diabetes compounds

June 4, 1997

Preclinical and clinical data support use of cerebrocrast as neuroprotectant

June 4, 1997

NEP/ACE/ECE inhibitors described by Wakamoto

June 4, 1997

NeoRx reaches milestone in Biostent development

June 4, 1997

U. of California discloses mammalian EPO-BP

June 4, 1997

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...